Kimberly-Clark is far from flashy, but what it lacks in glitz and glam, it makes up for with predictability.

Quick ReadPfizer's 7% yield and forward P/E of 8 complement Viatris's three FDA PDUFA decisions arriving before year-end 2026 ...

Kimberly-Clark has announced a planned $48.7b acquisition of Kenvue (NYSE:KVUE). The transaction is expected to lead to a ...

Kenvue Inc. (NYSE:KVUE) is one of the 10 Best Stocks to Buy According to Billionaire Glenn Dubin’s Highbridge Capital.

The transaction is expected to close in the second half of 2026, subject to shareholder approvals and regulatory approvals. DALLAS — Kimberly-Clark is expanding its worldwide innovation capabilities ...

Major U.S. equities indexes climbed Monday afternoon, boosted by gains in the tech sector as Nvidia announced a big ...

Kenvue stock has climbed 14.5% over the past month, yet there is a clear split in what different valuation lenses are saying, ...

Kenvue offers both a great short-term and long-term payoff to investors.

AUSTIN, Texas — Texas Attorney General Ken Paxton said he scored what he calls a "major win" against pharmaceutical giant Johnson & Johnson and its spinoff, consumer health company Kenvue. The ...

The beauty executive has been named managing director and operating partner.

Consumer healthcare company Kenvue, owner of the Neutrogena, Aveeno and Nicorette brands, has picked two agency network partners following a global review process. WPP will handle creative and ...